Market Tracker

06/28 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

28.26
Delayed Data
As of 4:00pm ET
 +0.62 / +2.24%
Today’s Change
20.68
Today|||52-Week Range
40.83
-2.01%
Year-to-Date

Today’s Trading

Previous close27.64
Today’s open27.77
Day’s range27.42 - 28.45
Volume1,104,050
Average volume (3 months)1,595,714
Market cap$3.4B
Dividend yield--
Data as of 4:00pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-20.80%
Earnings growth (next 5 years)+28.93%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book6.47

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+1.66+2.21%
PBYIPuma Biotechnology I...+4.00+4.71%
PTLAPortola Pharmaceutic...+1.01+1.86%
ICPTIntercept Pharmaceut...+0.98+0.80%
Data as of 4:00pm ET, 06/28/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts